Prognostic Impact of Corticosteroid and Tocilizumab Use Following CAR T-Cell Therapy for Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Blood Cancer J 2024 May 27;14(1)84, BA Costa, J Flynn, N Nishimura, SM Devlin, T Farzana, S Rajeeve, DJ Chung, HJ Landau, OB Lahoud, M Scordo, GL Shah, H Hassoun, K Maclachlan, M Hultcrantz, N Korde, AM Lesokhin, UA Shah, CR Tan, SA Giralt, SZ Usmani, K Nath, S MailankodyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.